|26 May 2021||
Merck Accelerates Scale Up of Lipids to Meet Covid-19 Demand
To meet the high demand for lipids, a key component of mRNA-based vaccines and therapeutics, Merck has launched a new, high-purity synthetic cholesterol product, nine months ahead of schedule.
|20 May 2021||
Merck Improves Lab Productivity Through Faster and More Sustainable Nucleic Acid Purification
Merck introduced a new solution improving productivity in the lab through a more flexible and streamlined nucleic acid purification process — GenElute™-E Single Spin purification kits.
|18 May 2021||
Merck Announces VectorY as Winner of its Advance Biotech Grant
Merck today announced that VectorY has been selected as the European winner of its 2021 Advance Biotech Grant Program.
|04 May 2021||
Merck Partners with Topco Scientific Co. to Increase Greener Manufacturing Materials Usage
Merck today announced a partnership with Topco Scientific Co. (TSC), a leading semiconductor supplier in Taiwan, to increase the use of more sustainable materials for the electronics industry.
|31 Mar 2021||
Merck Establishes Collaboration Laboratory with Universitas Indonesia to Advance Life Science Research
Merck today announced a strategic partnership with the Faculty of Mathematics and Natural Sciences, Universitas Indonesia (FMIPA-UI) to establish the first Collaboration Laboratory between the company and the university to advance life science research and innovation development in Indonesia.
|17 Mar 2021||
Merck Accelerates European Expansion Plans for Single-use Products Critical to Manufacturing Vaccines and Lifesaving Therapies
Merck will add a single-use assembly production unit at its Life Science Center in Molsheim, France.
|16 Mar 2021||
Merck Brings New Renewable Energy to the Grid through Virtual Power Purchase Agreement with Enel Green Power
As part of its ongoing commitment to renewable energy, Merck has signed a 12-year, off-site, virtual power purchase agreement with Enel Green Power for the construction of a future wind and storage project in Texas.
|25 Feb 2021||
Merck to Manufacture Next-Generation Biotherapeutics for Alteogen
Merck today announced an agreement with Alteogen, Inc., of South Korea, providing late-stage CDMO services through Merck BioReliance® End-to-End Solutions.
|15 Feb 2021||
Merck Enhances Design for Sustainability Framework, Offers Customers Data-Driven Insights for Greener Solutions
Merck today launched an enhanced Design for Sustainability (DfS) framework, a unique approach to holistically integrate sustainability into Life Science products, systems and services.
|04 Feb 2021||
Merck Continues Commitment to Science Education and Equity with Leading Non-Profits Around the World
Merck today announced seven expanded partnerships with leading nonprofit organizations across the world.
|07 Jan 2021||
Merck Acquires AmpTec to Expand mRNA Capabilities for Vaccines, Treatments and Diagnostics
Merck today announced the acquisition of AmpTec, a leading Hamburg, Germany-based, mRNA contract development and manufacturing organization (CDMO).
|07 Dec 2020||
Merck Expands Life Science Production Capacities in the United States
Merck today announced the broadening of its manufacturing footprint with a combined € 40 million investment at its production facilities in Danvers, Massachusetts, and Jaffrey, New Hampshire, USA.
|20 Nov 2020||
Massachusetts-based Businesses of Merck KGaA, Darmstadt, Germany named to The Boston Globe’s ‘Top Places to Work’ List
Merck KGaA, Darmstadt, Germany, today announced that its Massachusetts-based businesses, MilliporeSigma, EMD Serono and EMD Performance Materials, have again been named to The Boston Globe’s annual “Top Places to Work 2020” list.
|07 Nov 2020||
Merck and Transcenta Collaborate to Advance Continuous Biomanufacturing, Make the ‘Facility of the Future’ a Reality
Merck and Transcenta, a global biotherapeutics company, have announced a strategic technology collaboration to implement continuous manufacturing for protein therapeutics.
|06 Nov 2020||
Merck to Collaborate with Donghao Lansheng to Pilot New Import Policy in China
Merck today announced the signing of a Letter of Intent with Donghao Lansheng (Group) Co., Ltd.
|10 Nov 2020||
Merck’s Latest Technologies Earn Industry Recognition for Accelerating Bioprocessing 4.0
Merck today announced that its first-to-market Blazar™ platform from the BioReliance® portfolio has won R&D 100 and CPhI Awards for its ability to reduce testing times by up to 80 percent.
|29 Oct 2020||
Merck Collaborates with Mammoth Biosciences to Scale New SARS-CoV-2 Test
Merck today announced a collaboration with Mammoth Biosciences Inc., of South San Francisco, California, for the development, scale-up and commercial production of Mammoth’s CRISPR-based SARS CoV-2 diagnostic test.
|19 Oct 2020||
Merck Awards Grant to Combined Therapeutics for its Nucleic Acid Platform That, with Virotherapy, Targets Liver Cancer
Merck today announced that Combined Therapeutics Inc., Cambridge, Massachusetts, USA, has been selected as the North American winner of its 2020 Advance Biotech Grant Program.
|13 Oct 2020||
Merck New VirusExpress™ Platform Speeds Development of Cell and Gene Therapies
Merck has bolstered its viral vector manufacturing capabilities with the launch of its VirusExpress™ Lentiviral Production Platform.
|12 Oct 2020||
Merck Licenses CRISPR Genome-Editing Technology to PanCELLa and Takara Bio USA
Merck today announced that it has signed agreements licensing its CRISPR technology to two companies — PanCELLa, a cell therapy firm based in Toronto, Canada and Takara Bio USA, Inc., a biotechnology company based in Mountain View, California, USA.
|08 Oct 2020||
Merck Celebrates Topping-Out Ceremony for New Membrane Production Plant
Merck today celebrated the topping-out ceremony for its new membrane production plant in Darmstadt, Germany.
|08 Oct 2020||
Merck Supporting Innovation in China with D1Med Collaboration
Merck Merck, a leading science and technology company, is collaborating with D1Med, a Shanghai-based biopharmaceutical start-up precision-medical company, to accelerate production of D1Med’s 3D cell culture technology applications used in the drug discovery process.
|06 Oct 2020||
MilliporeSigma Inaugurates New, Upgraded Onsite Industrial Water Treatment Plant
MilliporeSigma today inaugurated a new $14.4 million industrial water treatment plant at its Jaffrey, New Hampshire, location.
|15 Sep 2020||
Merck Expands BioReliance® Viral Clearance Offering in Singapore, Saving Customers Time
Merck today announced an expansion of its Singapore biosafety testing laboratory services.
|09 Sep 2020||
Merck Announces € 59 Million Antibody-Drug Conjugate Manufacturing Expansion
Merck today announced a € 59 million expansion of its HPAPI and ADC manufacturing capabilities and capacity at its facility near Madison, Wisconsin, USA.
|03 Sep 2020||
Merck Supports Eijkman Institute to Expedite Covid-19 Vaccine Development Research
Merck today announced the donation of research instruments and materials worth IDR 1.2 billion (€ 74,000) to support the efforts of Eijkman Institute for Molecular Biology, Indonesia, in its efforts to accelerate vaccine development research. The institute is developing a Covid-19 vaccine based on a local virus strain, in collaboration with several local research institutions.
|30 Jul 2020||
Merck’s DOZN™ Green Chemistry Tool Named Top Project of the Year by Environment + Energy Leader
Merck today announced that it won a Top Project of the Year award from Environment + Energy Leader for its DOZN™ system, a quantitative tool that evaluates the relative greenness of chemicals and chemical processes against the 12 Principles of Green Chemistry.
|15 Jul 2020||
Merck Invests € 18 Million in New Life Science Laboratory in Switzerland
Merck has announced plans to build a new, € 18 million laboratory facility in Buchs, Switzerland to support the company’s rapidly growing reference materials business.
|10 Jul 2020||
Merck Opens its Largest M Lab™ Collaboration Center in Shanghai
Merck opened its M Lab™ Collaboration Center in Shanghai, the company’s largest of nine centers worldwide.
|06 Jul 2020||
Merck Announces VAR2 Pharmaceuticals as Winner of its Advance Biotech Grant
Merck today announced that VAR2 Pharmaceuticals has been selected as the European winner of its 2020 Advance Biotech Grant Program.
|01 Jul 2020||
New Report Identifies Paths to Pandemic Resilience
A new report details potential paths to solutions to overcoming the global Covid-19 crisis and ways to prepare for or even prevent a future pandemic.
|01 Jul 2020||
Merck Advances Bioprocessing Capabilities with Raman Technology Sensor Acquisition
Merck today enhanced its advanced bioprocess portfolio through the acquisition of RESOLUTION Spectra Systems.
|10 Jun 2020||
Merck and 10x Genomics Launch Powerful New Option for CRISPR Research
Merck and 10x Genomics, Inc., a single cell and spatial genomics technologies company, today announced that they have developed a powerful new option for biological experiments.
|27 May 2020||
Merck and Baylor College of Medicine Collaborate to Advance a Vaccine Manufacturing Platform to Fight Covid-19
Merck and Baylor College of Medicine, Houston, Texas, USA, today announced an extension of their ongoing collaboration to advance a manufacturing platform to fight Covid-19.
|11 May 2020||
Merck Granted U.S. Patents for Foundational CRISPR-Cas9 Technology
Merck today announced that two of its CRISPR-Cas9-assisted genome-editing patents have been allowed in the United States.
|30 Apr 2020||
Merck Accelerates Readiness of Bioprocessing Facility of the Future
Merck today unveiled the next component of its BioContinuum™ Platform, the Bio4C™ Software Suite, creating a first-of-its-kind ecosystem that combines process control, analytics and plant-level automation.
|21 Apr 2020||
Merck Boosts Commercial Viral Vector and Gene Therapy Manufacturing Capacity
Merck today announced a second Carlsbad, California, U.S.A.-based facility for its BioReliance® viral and gene therapy service offering.
|14 Apr 2020||
Merck Supports Jenner Institute to Reach First Milestone in Covid-19 Vaccine Manufacturing
Merck and The Jenner Institute today announced that the Jenner Institute has laid the foundation for large-scale production of its Covid-19 vaccine candidate, ChAdOx1 nCoV-19.
|07 Apr 2020||
Merck Awarded Second U.S. Patent for CRISPR Gene-Editing Technology
Merck today announced that the United States Patent and Trademark Office has granted the company’s patent for CRISPR-chrom technology.
|03 Mar 2020||
Merck’s New LANEXO™ System to Improve Scientists’ Productivity in the Lab
Merck today launched its LANEXO™ Lab Inventory, Safety and Compliance Management System, a new digital laboratory informatics solution designed to drastically reduce time in labs and improve data quality and traceability.
|18 Feb 2020||
Merck to Manufacture Elypta’s Liquid Biopsy Kits
Merck today announced that it has been selected by Swedish molecular diagnostics firm Elypta as the contract manufacturer for Elypta’s clinical diagnostic liquid biopsy kits.
|11 Feb 2020||
Merck’s New BrightLab™ Cloud-hosted Software Brings IoT to R&D
Merck today introduced its BrightLab™ cloud-based inventory management and instrument connectivity platform for research scientists.
|10 Jan 2020||
Merck and CSIR-IMTECH Open High-tech Skill Development Center
Merck today announced the opening of new, non-profit center where Indian students and researchers can learn the latest genome-editing and single-molecule biomolecule biomarker detection technologies.
|19 Dec 2019||
Merck Licenses Foundational CRISPR Integration Technology to Promega
Merck today announced that it has signed a license agreement providing Promega Corp.
|26 Nov 2019||
Japan and Singapore Grant CRISPR Patents to Merck
Merck today announced that the Japan Patent Office and the Intellectual Property Office of Singapore have each allowed the company’s patent application for the use of paired CRISPR nickases.
|18 Nov 2019||
Merck Wins R&D 100 Award for First-to-Market Biopharma Purification Innovation
Merck today announced it has received a prestigious R&D 100 Award for its Eshmuno® CP-FT Resin, a first-to-market product used in biopharmaceutical manufacturing.
|18 Nov 2019||
Merck Expands in Gillingham, UK, Boosts Distribution Capabilities
Merck today announced the completion of a £9 million expansion to its Gillingham distribution centre.
|12 Nov 2019||
Merck Licenses CRISPR Gene-Editing Technology to Evotec
Merck today announced that it has signed a license agreement providing Evotec SE access to Merck’s foundational CRISPR intellectual property.
|10 Oct 2019||
Merck Becomes the First to Use Acoustic Technology for Cell Therapy Manufacturing
Merck today announced it has acquired FloDesign Sonics, of Wilbraham, Massachusetts, USA, developer of a unique acoustic cell processing platform for the industrialization of cell and gene therapy manufacturing. Financial details were not disclosed.
|19 Sep 2019||
Merck Launches First Flagship Store on Alibaba’s 1688.com to Improve the Customer Experience
Merck has launched its official flagship store (merckls.1688.com) on Alibaba’s 1688.com.
|19 Aug 2019||
Merck Granted 20 CRISPR Patents Total Worldwide
Merck today announced that the European, Israeli, South Korean and U.K. intellectual property offices have issued formal notices allowing seven additional Merck patent application claims covering CRISPR gene-editing technology, bringing the number of patents to 20 worldwide.
|06 Aug 2019||
Merck Acquires BSSN Software to Accelerate Customers’ Digital Transformation in the Lab
Merck has acquired BSSN Software, a Darmstadt, Germany-based laboratory informatics company that makes data more readily accessible for ease of integration, collaboration, analysis and long-term archiving.
|24 Jul 2019||
Merck to Provide BioReliance® End-to-End Solutions to Phanes Therapeutics
Merck today announced the signing of a non-binding Memorandum of Understanding (MoU) with Phanes Therapeutics, Inc. (Phanes) for a collaboration on the development and manufacture of biologics for the treatment of solid tumors.
|18 Jul 2019||
Merck and Broad Institute Announce CRISPR License Framework to Encourage Innovation
Merck and the Broad Institute of MIT and Harvard (Boston, Massachusetts) today announced an agreement to offer non-exclusive licenses to CRISPR intellectual property (IP) under their respective control for use in commercial research and product development.
|20 Jun 2019||
Massachusetts-based Business Sectors of Merck KGaA, Darmstadt, Germany Named ‘Best Places to Work’ by Boston Business Journal
MilliporeSigma, EMD Serono and EMD Performance Materials make prestigious Massachusetts top employer list for 2019
|20 Jun 2019||
Merck Introduces Mobile Laboratory to Promote Protein Research
Merck today announced a national campus tour in China for the company’s first mobile protein research laboratory.
|30 May 2019||
Merck Awards Grants to Biotechs Focused on Traumatic Brain Injury, Vaccine Development and Chronic Pain
Merck today announced the winners of its Advance Biotech Grant program in North America during its Biotech Start-up Summit at the Cambridge Innovation Center (Massachusetts, U.S.).
|29 May 2019||
Merck Announces Winners of School Science Competition
Merck today announced that students from St Aloysius’ College in Carrigtwohill have won the company’s 2019 School Science Competition, now in its 15th year.
|27 May 2019||
Merck Expands Cell Culture Media Production Facility in Irvine
Merck today announced the completion of a £2.7 million expansion to its Irvine biopharmaceutical production facility.
|22 May 2019||
Experts Discuss Decentralized Manufacturing to Tackle Neglected Tropical Diseases and Promote Universal Health Coverage at World Health Assembly Event
Merck today hosted a panel discussion on the occasion of the 72nd World Health Assembly in Geneva, Switzerland.
|20 May 2019||
Merck Joins TRANSVAC2 Program to Advance Vaccine Development and Manufacturing
Merck today announced its participation in a collaboration with the Vaccine Formulation Institute and the European Vaccine Initiative.
|07 May 2019||
Merck Announces Winner of First Retrosynthetic Reaction Prediction Contest
Merck today announced that MDL, a team from Beijing University, has won the company’s first Retrosynthetic Reaction Prediction Contest.
|30 Apr 2019||
Merck and India’s Food Safety and Standards Authority Partner on Skill Development in Food Safety
Merck today announced the handover of a fully equipped microbiological testing laboratory to the Food Safety and Standards Authority of India (FSSAI).
|24 Apr 2019||
Merck Introduces New Greener Solvent, Cyrene™
Merck today launched Cyrene™ — a sustainable dipolar aprotic solvent, produced in two steps from a renewable cellulose source.
|04 Apr 2019||
Merck Recognized with INTERPHEX Exhibitor Award for Best New Product
Merck today announced that it has won an INTERPHEX Exhibitor Award for a new innovation in advancing next-generation bioprocessing. Merck’s Pellicon® Capsule with Ultracel® Membrane has been recognized for Best New Product.
|02 Apr 2019||
Merck Elevates its BioContinuum™ Platform Strategy to Deliver ‘ContiGuous’ Bioprocessing
Merck today unveiled its BioContinuum™ Buffer Delivery Platform, a new building block in the BioContinuum™ Platform for next-generation bioprocessing.
|20 Mar 2019||
Merck Opens First M Lab™ Collaboration Center in Europe
Merck today officially opened its new M Lab™ Collaboration Center in Molsheim, France.
|18 Mar 2019||
Merck’s Milli-Q® Connect Combines Deep Water Purification Expertise with Cloud-based Digital Technology
Merck today announced a new cloud-based, remote lab water service and monitoring capability available on all Milli-Q® CLX 7000 clinical water purification systems.
|19 Mar 2019||
Merck To Collaborate with GenScript to Accelerate Cell and Gene Therapy Industrialization in China
Merck today announced the signing of a non-binding Memorandum of Understanding with Chinese biotech company GenScript for a strategic alliance focusing on plasmid and viral vector manufacturing.
|14 Mar 2019||
Zhejiang University Joins Merck’s CRISPR Core Partnership Program
Merck today announced a CRISPR core partnership with Zhejiang University in Hangzhou, China.
|07 Mar 2019||
MilliporeSigma Brings Science Education to Students Across North America with Curiosity Cube® Mobile Science Lab
MilliporeSigma is igniting student interest in science with its third annual Curiosity Cube® mobile science lab tour.
|04 Mar 2019||
Merck Awarded Canadian CRISPR Nickase Patent for Foundational Genome-Editing Technology
Merck today announced that the Canadian Patent Office has allowed Merck’s patent application directed to the use of paired CRISPR nickases in eukaryotic cells.
|19 Feb 2019||
Merck Receives First U.S. Patent for Improved CRISPR Genome-Editing Method
Merck today announced that the United States Patent and Trademark Office has issued a formal notice allowing Merck’s patent application directed to its proxy-CRISPR technology.
|04 Feb 2019||
Merck Awards Grants to Biotechs Tackling Cancer and Cardiovascular Disease
Merck today announced the winners of its Advance Biotech Grant program in Europe.
|15 Jan 2019||
Merck Wins Life Science Industry Award® for Best Use of Social Media
Merck today announced that it has been recognized by BioInformatics LLC with a 2018 Life Science Industry Award® for best use of social media.
|19 Dec 2018||
Merck Collaborates with Kuraray to Improve Drug Delivery
Merck today announced it has extended and expanded its collaboration with Kuraray Europe to exclusively supply pharmaceutical polyvinyl alcohol (PVA) grades and improvements to benefit the pharmaceutical market.
|10 Dec 2018||
Merck and genOway Form CRISPR/Cas9 Strategic Alliance to Develop Rodent Models
Merck today announced a strategic alliance in the CRISPR/Cas9 rodent model market with France-based biotechnology company genOway.
|27 Nov 2018||
Merck Wins Two R&D 100 Awards for Innovation in 2018
Merck today announced that it has won two R&D 100 Awards.
|19 Nov 2018||
Merck Announces Winners of 2018 Life Science Awards
Merck recognized three graduate students who have demonstrated innovation in life science at an awards ceremony at the company’s global headquarters in Darmstadt, Germany recently.
|05 Nov 2018||
Merck Launches BioContinuum™ Platform for Next-Generation Process Improvements
Merck today launched its new BioContinuum™ Platform to advance biotherapeutic drug manufacturing through improved efficiency, simplified plant operations and greater quality and consistency.
|18 Oct 2018||
Merck Announces Agreement to Sell Amnis® Flow Cytometry and Guava® Technologies Businesses to Luminex Corporation
Merck today announced the signing of a definitive agreement to sell its Flow Cytometry unit to Luminex Corporation for €62.5 million.
|12 Oct 2018||
Merck Recognized with CPhI Awards for Innovative Products
Merck announced that it has won two CPhI Pharma Awards for innovative products for the pharmaceutical industry.
|04 Oct 2018||
Merck Opens M Lab™ Collaboration Center in São Paulo, Brazil
Merck today officially opened a state-of-the-art M Lab™ Collaboration Center in Brazil, serving the Latin America region.
|02 Oct 2018||
Merck Announces $3,000 Grand Prize Winner of Alfred R. Bader Award for Student Innovation
Merck recognized four graduate students for their research and innovations in synthetic organic chemistry as part of the Alfred R. Bader Student Chemistry Symposium in Darmstadt, Germany, on September 27.
|18 Sep 2018||
Merck Makes Major Investment in New Singapore Laboratory
Merck today announced the opening of a new 3,800-square-meter laboratory in Singapore.
|12 Sep 2018||
Merck to Open China’s First Mobius® Single-use Manufacturing Facility in Wuxi
Merck today announced the establishment of its first Mobius® Single-use Manufacturing Facility in China.
|04 Sep 2018||
Merck Launches Next-Generation Process Technologies for Intensified Drug Production
Merck today launched three new products to help biomanufacturers navigate the evolving biopharma landscape with increased speed, greater flexibility and enhanced quality.
|15 Aug 2018||
Merck Awarded Australian CRISPR Nickase Patent for Foundational Genome-Editing Technology
Merck today announced that the Australian Patent Office has allowed the company’s patent application for the use of paired CRISPR nickases.
|26 Jul 2018||
Merck and InnoCore Pharmaceuticals to Improve Patient Compliance with New Drug Delivery Technology
Merck and InnoCore Pharmaceuticals; Groningen, Netherlands, have entered into a global cooperation agreement to provide InnoCore’s proprietary SynBiosys® biodegradable polymer platform.
|02 Jul 2018||
Merck to Expand Operations in Gillingham, UK
Merck today announced plans to expand its Gillingham, UK distribution centre.
|20 Jun 2018||
Tongji University Joins Merck’s CRISPR Core Partnership Program
Merck today announced a new CRISPR core partnership with Tongji University in Shanghai.
|19 Jun 2018||
Merck Signs Exclusive Agreement with HistoCyte Laboratories to Distribute Pathology Technology
Merck today announced that it has entered into an agreement with HistoCyte Laboratories Ltd, Tyne, U.K., to be the exclusive multinational distributor of the company’s portfolio of cell line reference products for immunohistochemistry and in situ hybridization.
|12 Jun 2018||
Merck Drives Thought Leadership in Ethical Gene Editing
Merck today announced that The American Journal of Bioethics has accepted a novel publication on ethical issues in genome editing to be printed in its July issue.
|06 Jun 2018||
Merck Completes Third and Final Registration Phase under the European Chemicals Regulation REACH
Merck today announced that it has successfully submitted a total of more than 1,000 registration dossiers under the European chemicals regulation REACH by the end of the third and final registration deadline of May 31, 2018.
|05 Jun 2018||
Merck Brings Biotechs Closer to Drug Therapy Production and Commercialization
Merck today officially opened North America’s first BioReliance® End-to-End Biodevelopment Center in Burlington, Massachusetts, U.S.A., providing cell line development services, upstream and downstream process development and non-GMP clinical production for drug manufacturers.
|29 May 2018||
Merck Announces Collaboration with Solvias for New Pyrogen Detection Kit
Merck today announced a collaboration with Solvias, a Swiss contract research and service provider, to offer the PyroMAT™ System, a new MAT kit for pyrogen detection.
|16 May 2018||
Merck to Use Genome Editing in Study of Gut Bacteria to Benefit Malnourished Children
Merck today announced a collaboration with Washington University in St. Louis, Missouri, USA, that could lead to the optimizing of nutritional supplements to restore a healthy gut microbial community (microbiome).
|27 Apr 2018||
Merck Advances Cell Analysis with New Benchtop Flow Cytometer with Camera Detection
Merck today launched its new CellStream™ benchtop flow cytometry system, a compact, customizable flow cytometer that uses a camera for detection.
|23 Apr 2018||
Merck Receives Patent for CRISPR Technology in China
Merck today announced that the Chinese Patent Office has issued a notice granting Merck’s patent application for the company’s CRISPR technology used in a genomic-integration method for eukaryotic cells.
|18 Apr 2018||
Merck Wins INTERPHEX Exhibitor Award for Best Technological Innovation
Merck today announced that its Millistak+® HC Pro portfolio has won an INTERPHEX Exhibitor Award for Best Technological Innovation.
|17 Apr 2018||
Merck Introduces New Single-use Technologies to Advance Flexible Manufacturing
Merck today introduced three new products to support flexible manufacturing of biologics.
|12 Apr 2018||
Merck Helps Accelerate Global Access to Affordable Vaccines
Merck today announced a partnership with Oxford University’s Jenner Institute to develop more robust and scalable vaccine manufacturing processes.
|28 Mar 2018||
Merck Named Best Bioprocessing Supplier in Asia
Merck was named the overall “Best Bioprocessing Supplier” and won the sub-category of “Best Bioprocessing Supplier Award for Single-use Systems” at the Asia-Pacific Bioprocessing Excellence Awards 2018 ceremony.
|05 Mar 2018||
Merck and Schneider Electric Sign MoU to Advance China’s Biopharmaceutical Industry
Merck and Schneider Electric, a global specialist in energy management and automation, today announced the signing of a Memorandum of Understanding (MoU) that aims to automate the mAb process for China’s biopharmaceutical industry.
|28 Feb 2018||
Merck Furthers Scientists’ Research Through Expanded Seeding Labs Partnership
Merck today announced an expansion of its partnership with Seeding Labs to accelerate teaching and research for thousands of scientists in the developing world.
|27 Feb 2018||
Merck Announces €300,000 in Grants to Accelerate Therapeutic Research in Life Science
Merck today announced the recipients of its Emerging Biotech Grant Program in China.
|26 Feb 2018||
MilliporeSigma Announces 2018 North American Curiosity Cube™ Mobile Science Lab Tour
MilliporeSigma today announced plans for its second annual Curiosity Cube™ mobile science lab tour, which will kick off in February and visit more than 100 communities in the U.S. and Canada.
|22 Feb 2018||
Merck Announces Investment in India with New Life Science Manufacturing & Distribution Centre
Merck today announced that it will invest €16.6 million in its new manufacturing and distribution centre for the Life Science business, located near Mumbai, India.
|22 Feb 2018||
Merck Signs Agreement with Incheon Free Economic Zone to Build Cell Culture Facility in South Korea
Merck today announced it has signed an agreement with Incheon Free Economic Zone (IFEZ) to build an integrated cell culture facility in Songdo, Incheon.
|22 Feb 2018||
Merck Accelerates Mobius® Single-Use Manufacturing in Wuxi
Merck today announced an additional investment to accelerate Mobius® single-use manufacturing in Wuxi, China.
|22 Feb 2018||
Merck Strengthens Corporate Responsibility Efforts with Nine New Signature Partnerships
Merck today announced nine new or expanded partnerships with leading nonprofit organizations across the world through its Life Science business sector.
|21 Feb 2018||
Merck Invests Additional €40 Million to Enhance Manufacturing and Distribution in Asia
Merck today announced an additional investment of €40 million to build a robust manufacturing and distribution platform in Asia over a span of two years.
|20 Feb 2018||
Merck Receives Two More Patents for CRISPR Technology
Merck today announced that the Korean Intellectual Property Office and the Israel Patent Office have each issued notices granting Merck’s patent applications for the company’s CRISPR technology.
|13 Feb 2018||
Merck Launches Viresolve® Barrier Capsule Filters to Protect Against Bioreactor Contamination
Merck today introduced Viresolve® Barrier capsule filters to reduce the risk of bioreactor contamination.
|01 Feb 2018||
Merck KGaA, Darmstadt, Germany Certified as one of the Top Employers North America 2018
For the second year in a row, the North American businesses of Merck KGaA, Darmstadt, Germany, a leading science and technology company, have been certified for the company’s outstanding employee offerings by the independent Top Employers Institute.
|20 Dec 2017||
Merck Collaborates with iCON™ to Offer BioReliance® End-to-End Turnkey Modular MAb Manufacturing Platform
Merck today announced a collaboration with IPS-Integrated Project Services, LLC and G-CON Manufacturing, Inc. to provide the most advanced 2,000L monoclonal antibody (MAb) facility and single-use process technology platform.
|20 Dec 2017||
Merck Signs Commercial Supply Agreement with bluebird bio for Viral Vector Manufacturing
Merck today announced that it has signed a commercial supply agreement to manufacture viral vectors for bluebird bio, Inc., of Cambridge, Massachusetts, USA, for its use in potentially transformative gene therapies.
|19 Dec 2017||
Singapore’s IP Office to Grant Merck’s Patent Application for CRISPR Technology
Merck today announced that the Intellectual Property Office of Singapore has issued a “Notice of Eligibility for Grant” for Merck’s patent application covering the company’s CRISPR technology.
|11 Dec 2017||
Merck Signs Distribution Agreement with Avanti® Polar Lipids
Merck today announced that it has entered into an agreement with Avanti® Polar Lipids to be the exclusive multinational distributor of the USA-based company’s research lipids portfolio outside of the United States.
|17 Nov 2017||
Merck KGaA, Darmstadt, Germany's Massachusetts-based Business Sectors Named 'Top Place to Work' by The Boston Globe
Merck KGaA, Darmstadt, Germany today announced that its Massachusetts-based business sectors, EMD Serono and MilliporeSigma, have been named to The Boston Globe's annual "Top Places to Work" list for the second year in a row.
|13 Nov 2017||
Merck Introduces Stericup® Quick Release System for Improved Cell Culture Filtration
Merck today launched the new Stericup® Quick Release 500 ml vacuum filtration system.
|01 Nov 2017||
Merck and Samsung BioLogics to Extend Strategic Alliance
Merck today announced the signing of a Memorandum of Understanding (MoU) with Samsung BioLogics for a strategic alliance on biopharmaceutical manufacturing and biologics process development.
|24 Oct 2017||
Canadian Patent Office to Grant Merck's Patent Application for CRISPR Technology
Merck today announced that the Canadian Patent Office has issued a “Notice of Allowance” for Merck’s patent application covering the company’s CRISPR technology.
|23 Oct 2017||
Merck Announces $10,000 Grand Prize Winners of 2017 Life Science Awards
Merck has recognized a group of outstanding postgraduate students for their research and innovations in life science at an awards ceremony.
|19 Oct 2017||
Merck Brings Customers Closer to Gene Therapy Product Commercialization
Merck today announced that its Carlsbad, California-based manufacturing facility for the production of BioReliance® viral and gene therapy products has completed both a U.S. Food & Drug Administration (FDA) Pre-License inspection and a European Medicines Agency (EMA) Marketing Authorization Application inspection.
|11 Oct 2017||
MilliporeSigma Opens New Life Science Center in Massachusetts for Scientific Collaboration
MilliporeSigma will welcome world-renowned academic researchers, technology experts and industry entrepreneurs to discuss advances and opportunities in some of the most exciting areas of life science on Wednesday, October 11, 2017, 10 a.m. at the company’s new Life Science Center in Burlington.
|10 Oct 2017||
Merck Presents ‘Future Forum’ at Boston’s HUBweek 2017
Merck will host a panel discussion, “The Personalized Cell Therapy Challenge: A Race Against Time,” featuring leading cell and gene therapy experts from academia, hospitals and industry.
|10 Oct 2017||
Merck Hosts Leading Scientists at Life Science Symposium in Greater Boston
Merck will welcome world-renowned academic researchers, technology experts and industry entrepreneurs to discuss advances and opportunities in some of the most exciting areas of life science on Wednesday, October 11, 2017, 10 a.m. at the company’s new Life Science Center in Burlington.
|27 Sep 2017||
Merck Provides Update on EU’s Horizon 2020 Program to Improve Biopharmaceutical Downstream Processing
Merck today announced an update on its participation in Horizon 2020, the EU Framework Program for Research and Innovation, to improve biopharmaceutical downstream processing.
|26 Sep 2017||
New, First-of-its Kind Filters by Merck Provide Twice the Filtration Capacity using Fully Synthetic Materials
Merck today announced Millistak+® HC Pro, the first portfolio of high- capacity, fully synthetic depth filters for non-treated Chinese Hamster Ovary (CHO) harvest clarification and downstream filtration applications.
|22 Sep 2017||
Merck Opens China’s First BioReliance® End-to-End Biodevelopment Center in Shanghai
Merck today announced the opening of its first BioReliance® End-to-End Biodevelopment Center in the Asia Pacific (APAC) region.
|20 Sep 2017||
Merck Introduces Eshmuno® P Anti-A and Anti-B Chromatography Resins for Enhancement of Plasma-Derived Immunoglobulin
Merck today launched Eshmuno® P anti-A and Eshmuno® P anti-B affinity chromatography resins specifically designed to remove anti-A and anti-B isoagglutinin antibodies during the manufacturing of plasma-derived immunoglobulin (Ig) therapies.
|13 Sep 2017||
Merck Expands Celonic’s Upstream Capabilities with Mobius® Single-use Bioreactors
Merck today announced that Celonic AG, a Swiss contract development and manufacturing organization (CDMO), is upgrading its manufacturing facility with five of Merck’s Mobius® single-use bioreactors.
|11 Sep 2017||
Merck Announces $5,000 Grand Prize Winner of Alfred R. Bader Award for Student Innovation
Merck recognized four student chemists for their research and innovations in synthetic organic chemistry as part of the Alfred R. Bader Student Chemistry Symposium.
|28 Aug 2017||
Merck to Acquire Natrix Separations to Advance Next-Generation Processing Capabilities
Merck today announced that it has entered into an agreement to acquire Natrix Separations, an Ontario, Canada-based provider of hydrogel membrane products for single-use chromatography.
|30 Aug 2017||
Merck Opens its First Customer Food Safety Studio
Merck has opened its first global Food Safety Studio in Bellevue, Washington for manufacturers of all types of food to collaborate with Merck scientists.
|29 Aug 2017||
Merck Collaborates with Angiex to Speed Clinical Readiness of New Cancer Therapy
Merck today announced a new collaboration with Angiex, Inc., Cambridge, Massachusetts, to support the biotechnology start-up’s ability to speed its lead oncology antibody drug candidate to clinical use.
|08 Aug 2017||
Merck and Baylor College of Medicine Advance Vaccine Development and Manufacturing for Neglected Diseases
Merck today announced that it has formed a strategic alliance with Baylor College of Medicine...
|03 Aug 2017||
European Patent Office to Grant Merck's Patent Application for CRISPR Technology
Merck today announced that the European Patent Office (EPO) has issued a “Notice of Intention to Grant” for Merck’s patent application covering the company’s CRISPR technology used in a genomic integration method for eukaryotic cells.
|27 Jun 2017||
Merck Wins False Advertising Lawsuit Against Distributor of RephiLe Bioscience Lab Water Products
Merck today announced that it has prevailed against Analis S.A. in a lawsuit ordering the Belgium-based laboratory equipment distributor to cease advertising that compares RephiLe Bioscience Ltd.’s lab water products with the lab water products of Merck.
|26 Jun 2017||
Merck adds Chemical Products to Reaxys’ Chemistry Database
Merck today announced a collaboration with Elsevier, the information analytics company specializing in science and health, to add its products into Reaxys, Elsevier’s chemistry database.
|15 Jun 2017||
Merck Expands Distribution Agreement with Public Health England
Merck today announced an expansion of its distribution alliance with Public Health England (PHE) to include the European Bank of induced pluripotent Stem Cells (EBiSC).
|14 Jun 2017||
Merck Awarded its First CRISPR Patent by Australian Patent Office
Merck today announced that the Australian Patent Office has granted the company patent rights over the use of CRISPR in a genomic integration method for eukaryotic cells.
|16 May 2017||
Merck’s CHOZN® Expression System Selected for Bi-specific Antibody Development by SystImmune
Merck today announced that its CHOZN® expression system will be used by SystImmune, a Seattle-based biotechnology company, for commercial development of a bi-specific antibody therapeutic.
|17 May 2017||
Merck Develops Alternative CRISPR Genome Editing Method
Merck has developed a new genome editing tool that makes CRISPR more efficient, flexible and specific.
|15 May 2017||
Merck Launches Industry’s First Off-the-Shelf Cell Culture Media for Perfusion Processes
Merck today took a significant step toward increasing manufacturing flexibility and enabling higher productivity with the launch of the EX-CELL® Advanced™ HD Perfusion Medium.
|12 May 2017||
Merck Opens New M Lab™ Collaboration Center in Bangalore
Merck today announced the expansion of its M Lab™ Collaboration Center in Bangalore, India.
|12 May 2017||
Merck Opens First Joint Bioprocess Scale-up Lab with Stelis Biopharma in India
Merck today announced the opening of its first joint Process Scale-Up Lab in Bengaluru, India to provide end-to-end solutions from process development to scale-up manufacturing for pre-clinical, clinical and commercial supply.
|09 May 2017||
Merck Acquires Grzybowski Scientific Inventions to Expand Chemical Synthesis Offering
Merck today announced the acquisition of Grzybowski Scientific Inventions (GSI), a company that developed the revolutionary computer-aided retro-synthesis tool, Chematica.
|01 May 2017||
MilliporeSigma’s Mobius® 2,000-liter Single-use Bioreactors to Expand Avid Bioservices’ Manufacturing Capabilities
MilliporeSigma and Avid Bioservices, Inc., today announced that Avid will upgrade its Myford clinical and commercial manufacturing facility with multiple Mobius® 2000-liter single-use bioreactors from MilliporeSigma.
|25 Apr 2017||
MilliporeSigma Collaborates with LabCentral to Foster Biotech Startups
MilliporeSigma announced today that the company will sponsor the Startup Program at LabCentral, a biotechnology incubator, in Cambridge, Massachusetts.
|20 Apr 2017||
Merck Provides Upgraded Manufacturing Capabilities to BioInvent with Single-use Mobius® Bioreactors
Merck has announced that BioInvent International AB, a Swedish company which develops novel immuno-regulatory antibodies to treat cancer, is upgrading and expanding its drug manufacturing facility with a full line of MilliporeSigma’s Mobius® single-use bioreactors.
|05 Apr 2017||
MilliporeSigma Announces First Stops in National Curiosity Cube™ Tour
MilliporeSigma has announced nine stops for the first half of its national, year-long Curiosity Cube™ tour.
|03 Apr 2017||
Merck Introduces Next-Generation High-Sensitivity Protein Detection Platform
Merck today announced the launch of its newest high-sensitivity detection platform, SMCxPRO™ technology, at the American Association for Cancer Research Annual Meeting in Washington, D.C.
|21 Mar 2017||
Merck Introduces Mobius® MyWay Portfolio for Customized Single-Use Assemblies
Merck today launched the Mobius® MyWay portfolio, a program that allows more flexibility, better supply predictability and shorter lead times for more efficient and safer drug manufacture.
|06 Mar 2017||
Merck Advances Lab Water Purification Technology with Milli-Q® IQ 7000 System
Merck today announced the global launch of the Milli-Q® IQ 7000 system, the seventh-generation Milli-Q® water purification innovation.
|15 Feb 2017||
Merck to Supply Single-use Systems to WuXi Biologics for Non-GMP Pilot Plant in Shanghai
Merck was selected by contract development and manufacturing organization WuXi Biologics to provide Merck’s Mobius® single-use systems and technologies to fully equip a non-GMP pilot plant in Shanghai, China.
|08 Feb 2017||
North American Businesses of Merck KGaA, Darmstadt, Germany Certified as 2017 Top Employer
Merck KGaA, Darmstadt, Germany has announced that its North American businesses have been certified by the Top Employers Institute for exceptional employee offerings.
|03 Feb 2017||
Merck Wins Scotland’s Life Science Award for Excellence in Community Engagement
Merck has received the 2017 Scotland’s Life Science Award for outstanding achievements in community engagement.
|23 Jan 2017||
Merck Announces Emerging Biotech Grant Program Winners
Merck today announced the winners of its Emerging Biotech Grant Program in Europe.
|12 Jan 2017||
MilliporeSigma Kicks Off Year-Long ‘Curiosity Cube™’ Tour
Recognizing that tomorrow’s discoveries depend on the next generation of scientists, MilliporeSigma has kicked off a year-long “Curiosity Cube™” tour.
|10 Jan 2017||
Merck Expands End-to-End Biodevelopment Centers in North America, China and Europe
Merck today announced the expansion of its end-to-end biodevelopment centers to meet increasing customer demand for its turnkey portfolio of bioprocessing products, manufacturing capabilities and industry leading technological expertise.
|04 Jan 2017||
Merck Acquires BioControl to Strengthen Position in Food Safety Testing
Merck today announced it has acquired BioControl Systems Inc., a global leader in food safety testing.
|18 Jan 2017||
Merck Launches First Commercial Screening Service to Predict Multiple Sources of DNA Damage
Merck has introduced CAN MultiFlow™ screening services to more accurately predict genotoxic and mode of action* properties of substances, ingredients and drug compounds
|13 Jan 2017||
Merck Introduces New Calibration Kit for In Vitro Diagnostic Use
Merck today announced the introduction of its new testosterone calibrator kit for in vitro diagnostic (IVD) use.
|17 Jan 2017||
Merck Opens Production Facility Exclusively for Meglumine in Spain
Merck today announced the opening of a facility in Mollet des Vallès, Spain dedicated to the manufacture of meglumine, an FDA-approved excipient for pharmaceuticals and a component of medical imaging contrast media.
|19 Dec 2016||
MilliporeSigma Announces Winner of Life Science Award in Bioseparations
MilliporeSigma today announced that Ying Li, from The Pennsylvania State University, has won the company’s Life Science Award in Bioseparations.
|16 Dec 2016||
MilliporeSigma Wins Life Science Industry Award® for Most Memorable Advertising
MilliporeSigma today announced that it has been recognized by BioInformatics LLC with a 2016 Life Science Industry Award® for most memorable advertising.
|05 Dec 2016||
Merck to Provide Provantage® End-to-End Services to Acticor Biotech SAS
Merck today announced that it will provide its Provantage® End-to-End services to Acticor Biotech SAS for accelerated development and manufacturing of Acticor’s antibody fragment used for the primary treatment of ischemic stroke.
|02 Dec 2016||
Merck Launches Parteck® MXP Excipient for Increased Solubility
Merck today introduced Parteck® MXP, a polyvinyl alcohol-based excipient that enhances solubility of a wide range of active pharmaceutical ingredients (APIs) with poor bioavailability.
|02 Dec 2016||
Merck Introduces MILLIPLEX® High Sensitivity Panel for Faster, More Economical Cytokine Assays
Merck today launched the MILLIPLEX® MAP Human High Sensitivity cytokine panel for faster and more cost-effective human cytokine assays.
|01 Dec 2016||
Merck Expands Distribution Agreement with Roche
Merck today announced an expansion of its distribution alliance with Roche to include the polymerase chain reaction (PCR) and quantitative real-time PCR (qPCR) enzyme products of Kapa Biosystems, a company acquired by Roche in 2015.
|30 Nov 2016||
Merck Collaborates with Evotec for Faster Target Identification Solution
Merck today announced that it has entered into a set of agreements with Evotec AG, whereby Evotec AG will provide screening services for Merck’s collection of genetic reagents such as CRISPR and shRNA libraries.
|18 Nov 2016||
MilliporeSigma named ‘Top Place to Work’ by The Boston Globe
MilliporeSigma today announced that it has been named to The Boston Globe’s annual “Top Places to Work” list.
|15 Nov 2016||
MilliporeSigma Wins US Search Award for ‘Best In-House’ Team
MilliporeSigma today announced that its digital acquisition marketing team won the 2016 US Search award for “Best In-House” team.
|14 Nov 2016||
Merck Launches Next-Generation Technology for Advanced Live Cell Imaging
Merck has launched the CellASIC® ONIX2 Microfluidic System for advanced live cell imaging.
|11 Nov 2016||
Merck Wins R&D 100 Award for Top Invention
Merck received a prestigious R&D 100 Award for its Sanger Arrayed Lentiviral CRISPR Libraries—the first of its kind CRISPR libraries.
|13 Oct 2016||
Merck Introduces First Certified Spiking Solution® of Heavy Labeled Thyroglobulin Protein
Merck today introduced the first Certified Spiking Solution® of intact, heavy labeled Thyroglobulin in SigMatrix®, a synthetic surrogate serum.
|06 Oct 2016||
Merck Unveils New State-of-the-Art M Lab™ Collaboration Center in Korea
Merck today announced the opening of an M Lab™ Collaboration Center in the Songdo district of Incheon, Korea, one of the fastest growing biotech hubs in Asia.
|05 Oct 2016||
Merck’s Udit Batra Receives ‘CEO of the Year’ Award from CPhI Pharma
Merck today announced that the CEO of its life science business, Udit Batra, was named “CEO of the Year” for 2016 by CPhI Pharma for his commitment to furthering life science innovation globally.
|26 Sep 2016||
Merck Launches Viresolve® Pro Shield H for More Robust, Economical Parvovirus Removal
Merck is launching the Viresolve® Pro Shield H for removal of parvoviruses from therapeutic protein feed streams.
|19 Sep 2016||
Merck’s New Steritest™ Symbio Pump Accessories Enable Faster, Safer Sterility Testing in Any Setting
Merck has introduced a set of Steritest™ Symbio Pump systems accessories that accelerate and streamline sterility testing workflows.
|14 Sep 2016||
Merck Joins DiViNe Consortium to Address Low Yields, High Costs of Vaccine Purification Processes
Merck has joined the DiViNe project, a European consortium of six companies to address the biggest challenges facing the development, manufacture and delivery of vaccines.
|13 Sep 2016||
Merck Lab Earns ISO Accreditation for Quality Control of Culture Media
Merck today announced that its microbiology quality control laboratory in Eppelheim, Germany is now accredited for the quality control of the ReadyPlate™ and ReadyTube™ culture media tested there.
|08 Sep 2016||
Merck Launches New Gene Editing Technology to Engineer Virus Resistant CHO Cell Lines
Merck today launched a first-of-its-kind gene editing technology to modify CHO cell lines to be resistant to minute virus of mice (MVM), a common contamination threat that remains despite the shift to chemically defined, animal component-free manufacturing processes.
|03 Aug 2016||
Merck Expands Portfolio of Certified Reference Materials for Applied Diagnostics and Testing
Merck today announced the expansion of its portfolio of Cerilliant® certified reference materials (CRMs) with nine new Certified Spiking Solutions® used in laboratories around the world.
|01 Aug 2016||
Merck to Provide Provantage® End-to-End Development and Manufacturing Services to Y-mAbs for Lead Antibody Compound
Merck will provide its Provantage® End-to-End development and manufacturing services to Y-mAbs Therapeutics, Inc. in support of Y-mAbs’ monoclonal antibody in late stage clinical development.
|19 Jul 2016||
Merck Starts Construction on $115 Million Multi-faceted Life Science Campus in Burlington, Massachusetts
Merck today announced plans to build a new campus in Burlington, Massachusetts that will serve as a major hub for the North American life science business of Merck.
|18 Jul 2016||
Merck Relaunches Customer Collaboration Centers with New Concept and M Lab™ Name
Merck is relaunching its global network of customer collaboration centers, providing customers a shared, exploratory environment with scientists and engineers working to solve their toughest biomanufacturing challenges and helping accelerate development of new therapies.
|13 Jul 2016||
Merck Advances Water Purification Systems with New High-Throughput Line
Merck today introduced the Elix® High-Throughput water purification system, providing laboratories with a reliable water purification solution for daily water volumes of up to 9000 liters.
|12 Jul 2016||
Merck Expands Excipients Portfolio, Adding Polymers for Sustained Release Injectables
Merck has entered into an agreement with PCAS S.A. (Longjumeau, France) to expand Merck’s excipients portfolio.
|28 Jun 2016||
Merck Expands Industry-Leading Emprove® Program to Include Filtration and Single-Use Products
Merck has expanded its industry-leading Emprove® risk assessment program to include a selection of products for filtration and single-use processing.
|28 Jun 2016||
Merck to Develop Next-Generation Purification Processes with International Vaccine Institute
Merck has entered a research agreement with the International Vaccine Institute (IVI) of Seoul, South Korea to help develop more robust, scalable vaccine manufacturing processes.
|07 Jun 2016||
Merck Announces Survey Results Exploring Biopharma Industry’s Evolving Risk Model
Merck today announced survey results of 250 global biopharmaceutical executives on how their companies will manage new risks associated with the changing biopharma landscape.
|11 May 2016||
Merck Expands Popular Line of Guava® Flow Cytometers
Merck is expanding its popular line of Guava® flow cytometers to include a high-power modulated green laser.
|10 May 2016||
Merck Showcases New Innovations at Analytica 2016
Merck will exhibit a new range of products and solutions at Analytica 2016, the international trade fair for laboratory technology, analysis and biotechnology, held May 10-13 in Munich, Germany.
|09 May 2016||
Merck Launches First Commercially Available Equine-Specific Multiplex Assay for Protein Biomarkers
Merck today announced the global launch of the first commercially-available equine-specific multiplex assay for protein biomarkers.
|04 May 2016||
Merck Builds on Leading Viral and Gene Therapy Service Offering with Capacity Expansion
Merck today announced an expansion of its Carlsbad, California facility to meet growing demand for viral and gene therapy products.
|02 May 2016||
Merck Expands Production Know-how to Deliver Full End-To-End Solution for Biopharma Industry
Merck today announced the expansion of its state-of-the art single use current good manufacturing process (cGMP) facility with the addition of the Mobius® 2000L single-use bioreactor.
|27 Apr 2016||
New Merck Products Bring Ease of Use to Single-Use
Merck is launching three Mobius® products that deliver improved efficiency and ease-of-use for biopharmaceutical manufacturing workflows.
|26 Apr 2016||
Merck Introduces First Multi-use Disposable Sterile Connectors for Biopharma at INTERPHEX 2016
Merck today announced the launch of its first-in-class Lynx® CDR connectors to improve fluid management in the biopharma industry.
|19 Apr 2016||
Merck Earns Accreditation for Quality Control of Culture Media
Merck has received accreditation for the quality control of dehydrated culture media tested at its Microbiology Quality Control Laboratory in Darmstadt.
|14 Apr 2016||
Merck Supports Next Generation of Scientists at USA Science & Engineering Festival
Merck today announced that it is participating in the 4th USA Science & Engineering Festival (USASEF), April 16-17, 2016 in Washington D.C.
|29 Mar 2016||
Merck’s CRISPR Epigenetic Activator Named to The Scientist’s Top 10 Innovation List
Merck today announced that The Scientist magazine has named the company’s CRISPR Epigenetic Activator one of its Top 10 Innovations of 2015.
|21 Mar 2016||
Merck Introduces IsoBag™ for Faster and Easier Transfer of Contact and Settle Plates
Merck today introduced the IsoBag™ for faster, easier and more convenient transfer of contact and settle plates to production isolators.
|07 Mar 2016||
Life Science Leader Merck Launches New Innovations at Pittcon 2016
Merck is launching a range of new products for separation and analysis at the Pittcon Conference and Expo 2016 in Atlanta, Georgia, March 6 – 10, the world’s largest conference for laboratory science.
|07 Mar 2016||
Merck Launches Global Science Education Program to Inspire Future Scientists
Merck today announced the launch of SPARK, a global skills-based volunteer program that provides community service opportunities for its network of nearly 19,000 life science employees, with a focus on science and education.
|08 Jan 2016||
Merck Donates to American Red Cross to Support Greater St. Louis Flood Victims
Merck today announced it has donated $10,000 to the American Red Cross of the Greater St. Louis Region in support of the organization’s flood relief efforts.
|16 Dec 2015||
Merck Honored by R&D Magazine for Innovation
Merck today announced it has received two prestigious R&D Magazine 100 awards – one for its lab water purification systems, and the other for a technology that allows researchers to investigate scientific questions they previously couldn’t address.
|18 Nov 2015||
Merck Completes Sigma-Aldrich Acquisition
Merck today announced the completion of its $ 17 billion acquisition of Sigma-Aldrich, creating one of the leaders in the $ 130 billion global industry to help solve the toughest problems in life science.
|20 Nov 2015||
Merck Intends to Launch Innovative System for Monitoring CD4 T lymphocytes and T cells throughout Africa
Merck today hosted a discussion with renowned researchers to discuss the intention to launch its innovative Muse® Auto CD4/CD4% System, a portable instrument for monitoring T cells and CD4 counts throughout Africa.
|18 Nov 2015||
Merck Launches Innovative System for Monitoring T cells in HIV patients in Nigeria
Merck today announced the launch of its innovative Muse® Auto CD4/CD4% System, a portable instrument for monitoring T cells and CD4 counts in HIV affected patients in Nigeria.
|09 Nov 2015||
Merck Launches Novel Cancer Stem Cell Identification Kit, Exclusively Licensed from Johns Hopkins University
Merck today introduced the new AldeRed™ ALDH Detection Kit for identifying and isolating cancer stem cells.
|26 Oct 2015||
Merck Introduces Parteck® SRP 80 Excipient for Sustained-Release Oral Solid Dose Formulations
Merck today introduced Parteck® SRP 80, a new functional excipient for oral sustained-release formulations.
|22 Oct 2015||
Merck to Provide Provantage® End-to-End Solution for Development and Manufacture of Biosimilars under Strategic Alliance with Turgut Ilaç
Merck today announced the Company has entered into a strategic alliance with Turgut Ilaç, a leading biosimilars company based in Turkey and will provide their Provantage® End-to-End services for development and manufacturing of biologics.
|21 Oct 2015||
Merck Introduces Millipore Express® PHF Hydrophilic Sterilizing-Grade Filters for Fast, Efficient and Economical Buffer Filtration
Merck today introduced Millipore Express® PHF (process protection, high-flux) hydrophilic filters for fast, efficient and economical buffer filtration.
|28 Sep 2015||
Merck Publishes White Paper Highlighting Importance of Emerging Biotech Companies for Discovery of New Drugs During Recent Emerging Biotech Executive Summit
Merck today announced that it has published an original white paper, recognizing the impact the emerging biotech community has on the future of healthcare.
|14 Sep 2015||
Merck Introduces Enhancements to its Emprove® Program of Pharmaceutical Raw Materials to Facilitate Risk Assessment
Merck today introduced enhancements to its industry-leading Emprove® portfolio of pharmaceutical raw materials.
|12 Aug 2015||
Merck Announces Charitable Contribution to Massachusetts Institute of Technology (MIT) for Development of Novel Ebola Diagnostic and Tracking Platform
Merck today announced it is providing the Massachusetts Institute of Technology (MIT) with a $50,000 charitable contribution to support the development of a novel diagnostic and tracking platform for Ebola.
|27 Jul 2015||
Merck Adds Protein Pegylation to Portfolio of Services for Biopharmaceutical Industry through Collaboration with celares GmbH
Merck today announced a collaboration with celares GmbH to provide pegylation services to customers developing protein-based therapeutics and biosimilars.
|16 Jun 2015||
Merck’s Additions to the MAS-100® Product Family of Microbial Air Samplers Deliver Improved Functionality for Pharmaceutical Manufacturers
Merck today announced three additions to its MAS-100® product family.
|15 Jun 2015||
Merck Introduces the Mobius® 2000 Liter Single-Use Bioreactor with Industry-leading Design for Ease-of-Use
Merck today introduced the Mobius® 2000 liter single-use bioreactor. The 2000 liter bioreactor joins the Mobius® stirred tank bioreactor portfolio (from 3 to 2000 liters) that provides the ultimate in flexibility, scalability, and convenience.
|15 Jun 2015||
Merck Expands Provantage® Biodevelopment Services with Addition of Provantage® Clone Generation Service
Merck today announced expansion of its Provantage® Biodevelopment Services to include a Clone Generation Service.
|02 Jun 2015||
Merck Introduces Compaction Technology to Improve Solubility and Facilitate Handling of Cell Culture Media Used in Biopharmaceutical Production
Merck today introduced a new technology that compacts dry powder cell culture media into granules, accelerating solubility and improving flowability and handling.
|01 Jun 2015||
Merck Congratulates Nancy Hopkins, Ph.D. of the Koch Institute for Integrative Cancer Research (MIT) as Recipient of 2015 Alice C. Evans Award
Merck today announced that Nancy Hopkins, Ph.D., Amgen, Inc. Professor of Biology (emerita), Biology Department and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT), is the recipient of the 2015 Merck Alice C. Evans Award for Leadership in Clinical Microbiology.
|01 Jun 2015||
Merck Launches Cellvento™ CHO Cell Culture Media Platform for Optimized Cell Growth and Productivity
Merck today announced the launch of its Cellvento™ CHO platform of cell culture media and companion feed formulations for batch, fed-batch and perfusion applications.
|21 May 2015||
Merck Introduces Single-Pass Tangential Flow Filtration with Pellicon® Cassettes for Increased Capacity, Recovery and Concentration
Merck today introduced single-pass tangential flow filtration (TFF) with Pellicon® cassettes, an enhanced application of Merck’s existing TFF technology that allows concentration of process streams without the recirculation required in traditional TFF.
|21 May 2015||
Merck Enters Into Agreement to Acquire Exclusive Rights to Singulex’s Ultra-Sensitive Single Molecule Counting (SMC™) Technology
Merck and Singulex, the developer and leading provider of Single Molecule Counting (SMCTM) technology for clinical diagnostics and scientific discovery, today announced that they have entered into a definitive agreement under which Merck will control and manage the Singulex Life Science Research business.
|06 May 2015||
Study Finds Merck’s Strat-M® Synthetic Membrane Comparable to Human and Animal Skin for Permeation Studies
Merck announced publication of a study showing that its Strat-M® synthetic membrane predicts skin permeation of chemical compounds during in vitro transdermal diffusion studies as effectively as human or animal skin.
|23 Apr 2015||
Merck Introduces Magna ChIRP™ RNA Interactome Kits for the Analysis of Chromatin-Associated RNAs
Merck today introduced Magna ChIRP™ RNA Interactome Kits, which allow researchers to more easily identify, recover and analyze regions of chromatin that interact with chromatin-associated RNAs such as long non-coding RNA (lncRNA).
|02 Feb 2015||
Merck Announces Agreement with Precision Biologics, Inc. to Provide Upstream Process Development Services
Merck today announced an agreement for providing upstream process development services for Precision Biologics, Inc., a Texas-based clinical-stage biotechnology company, to advance a preclinical monoclonal antibody.
|27 Jan 2015||
Merck Introduces New High-Performance Water Purification Systems with 24/7 Real-Time Monitoring and Remote Control
Merck today announced the introduction of its AFS® 40E / 80E / 120E and 150E water purification systems.
|19 Nov 2014||
Merck Launches Kit for Analyzing NFкB Translocation by Imaging Flow Cytometry
Merck today introduced the Amnis® NFкB Translocation kit, which allows researchers to better study the nuclear translocation of NFкB, a transcription factor that plays a central role in regulating key mammalian cell processes, including proliferation, inflammation, immune and stress responses.
|21 Oct 2014||
Merck Introduces PureFlex™ Plus Single-Use Process Container Film for High-Volume Biopharmaceutical Applications
Merck has expanded its single-use film offerings with the introduction of PureFlex™ Plus film, a robust, durable film used in the construction of Mobius® single-use process containers for biopharmaceutical manufacturing.
|06 Nov 2014||
Merck's guava easyCyte™ 12 Flow Cytometer Offers Improved Resolution Down to 0.2 μm
Merck offers new data demonstrating improved performance for its guava easyCyte™ 12 flow cytometer, a simple and powerful benchtop method for multicolor flow cytometry.
|03 Nov 2014||
Merck’s New SNAP i.d.® 2.0 System for Immunohistochemistry Minimizes Slide Handling
Merck has introduced the SNAP i.d.® 2.0 Protein Detection System for Immunohistochemistry (IHC), which streamlines immunohistochemistry workflows and significantly decreases slide handling time.
|22 Sep 2014||
Merck to Acquire Sigma-Aldrich to Enhance Position in Attractive Life Science Industry
Merck today announced that they have entered into a definitive agreement under which Merck will acquire Sigma-Aldrich for $17.0 billion (€13.1 billion), establishing one of the leading players in the $130 billion global life science industry.
|15 Sep 2014||
Merck Recognized for Technologically Advanced Products by R&D Magazine
Merck announced it has received two R&D Magazine 100 Awards for innovative products released to market in 2013.
|28 Aug 2014||
Compact, Easy-to-Use Steritest™ Symbio Pumps from Merck Leverage Industry Leading Technology for Improved Sterility Testing
Merck has launched Steritest™ Symbio Pumps for easier, safer and more reliable sterility testing of pharmaceutical products in laminar flow hoods, isolators and clean rooms.
|26 Aug 2014||
Merck Expands Biomanufacturing Sciences and Training Center in Japan and Announces Opening of New Location in Tokyo
Merck today announced the opening of a new Biomanufacturing Sciences Training Center (BSTC) facility in Tokyo.
|20 Aug 2014||
Merck Announces Strategic Alliance on Biopharmaceutical Manufacturing with Samsung BioLogics
Merck announced today that Merck and Samsung BioLogics signed an MOU (Memorandum of Understanding) for a strategic alliance on the biopharmaceutical business.
|05 May 2014||
Merck Millipore Expands Provantage® Upstream Bioproduction Services to the North American Market
Merck Millipore today announces the expansion of its upstream services into North America as part of its Provantage® Biodevelopment and Clinical Supply offering.
|09 Apr 2014||
Merck Millipore and VWR Extend Western European Distribution Agreement
The contract includes a range of Merck Millipore products and reagents for chemical and microbiological analysis
|17 Mar 2014||
Merck Millipore Announces Clinical Research, Licensing and Joint Development Agreement with Sysmex Corporation
This collaboration will use Merck Millipore’s flow cytometry technology as a platform to accelerate the creation of new, more powerful diagnostic tools for research in blood disorders.
|10 Mar 2014||
Merck Millipore Receives Grant from Massachusetts Life Sciences Center to Collaborate with Promethera Biosciences
This is one of four grants given to Life Science companies in Massachusetts to fund international collaboration as part of MLSC’s International Collaborative Industrial Program.
|04 Feb 2014||
Merck Millipore Introduces DRYPOUR™ Packaging System to Minimize Caking of Pharmaceutical Raw Materials
The DRYPOUR™ packaging system minimizes caking of hygroscopic salts used in pharmaceutical manufacturing during transport and storage.
|29 Jan 2014||
Merck Millipore Expands its EMPROVE® Raw Materials Portfolio to 400 Products
The portfolio includes EMPROVE® api for active pharmaceutical ingredients, EMPROVE® exp for excipients and EMPROVE® bio for biopharmaceutical materials.
|17 Dec 2013||
Merck Millipore Provides Disaster Relief to Typhoon Haiyan Victims
Merck Millipore is providing product and monetary donations to assist those severely affected by Typhoon Haiyan in the Philippines.
|23 Oct 2013||
Merck Millipore Launches CpGenome™ Direct Prep Bisulfite Modification Kit for Simplified One-Step Conversion of Unmethylated Cytosines
By eliminating the need to isolate genomic DNA prior to performing bisulfite analysis, the kit provides a simple and reliable protocol for one-step bisulfite conversion.
|08 Nov 2013||
Merck Millipore Wins R&D Magazine 100 Award for its Direct Detect® Protein Quantitation System
The Direct Detect® system was recognized as one of R&D Magazine’s 100 most innovative and technologically significant products to be introduced into the marketplace.
|07 Nov 2013||
Merck Millipore Donates $10,000 to Environmental and Energy Study Institute in Recognition of Energy Month
The donation will specifically support EESI’s Transportation and Communities Program, which emphasizes energy efficiency and renewable energy across the transportation sector.
|16 Oct 2013||
Merck Millipore to be Global Distributor for SmartRNAplex™ MicroRNA Profiling Assay
MicroRNA detection with SmartRNAplex requires just three steps: hybridize, label, and report.
|22 Oct 2013||
Merck Millipore Introduces Parteck® SLC, Silica-based Excipient for Enhanced Drug Solubility and Bioavailability
Featuring a unique pore structure, Parteck SLC for drug delivery enables loading of oral dosage forms with amorphously distributed API to the highest levels.
|22 Oct 2013||
Merck Millipore Introduces the First Online Original Manufacturer Tracking Tool
The electronic Original Manufacturer Tracking (eOMT) saves users valuable time in research and enables compliance with regulatory requirements.
|10 Oct 2013||
Beijing Higher Court Rules in Favor of Merck Millipore in Patent Infringement Case
The Court determined that RephiLe’s accused products fall into the protection scope of Merck Millipore’s patent.
|12 Sep 2013||
Merck Millipore Receives Recertification of GMP Compliance for Biodevelopment Centre in Martillac, France
Merck Millipore today announced that its Biodevelopment Centre in Martillac, France, has been recertified by the French National Agency for Medicines and Health Products Safety (ANSM), the competent authority of France.
|26 Sep 2013||
Merck Millipore Accepts Stevie Awards for Direct Detect® and Muse® Products at the 2013 American Business Awards
These awards were distributed by the American Business Awards, the premier business award program in the United States - finalists were announced in June.
|19 Apr 2012||
Merck Millipore Live Lab Tour 2012 to Visit Science Zones in Europe
The “Live Lab,” a 60-square-meter exhibition space housed in an eye-catching coach-style vehicle, is a novel way to bring information about new technologies right to the workplace.
|07 Feb 2012||
Merck Millipore Introduces Elix® Essential 3, 5, 10, 15 Water Purification Systems
The new systems integrate patented Elix electrodeionization (EDI) technology along with several other complementary water purification techniques.
|25 Jan 2012||
Merck Millipore Enhances Range of Direct-Q® 3, 5, 8 Water Purification Systems
First launched in 2005, the Direct-Q systems met with immediate and continuing success
|21 Feb 2012||
Merck Millipore Introduces AFS® 10E and AFS® 15E Water Purification Systems
The Merck Millipore AFS 10E and AFS 15E water purification systems integrate patented Elix® electrodeionization (EDI) technology along with several other complementary water purification techniques
|19 Jun 2012||
Merck Millipore Introduces AFS® 8D and AFS® 16D Degassed Water Purification Systems
The new systems are designed to provide cost-effective, low-maintenance solutions for clinical analyzers requiring degassed clinical laboratory reagent water (CLRW).
|25 May 2011||
Merck Millipore Introduces Bottled Water with Certified Water Quality
Water for Cell Culture and Water for Molecular Biology are produced in an ISO® 9001 / cGMP environment. The bottled water is subject to strict quality control tests.
|08 Mar 2011||
Merck Millipore Introduces All-in-One Water Purification System for High-Volume Clinical Analyzers
The Elix Gulfstream Clinical water purification system will provide up to 100 liters per hour and 2000 liters of clinical laboratory reagent water (CLRW) daily
|18 Sep 2013||
Merck Millipore Donates $5,000 and School Supplies for Children in Need
Merck Millipore Teams Up with the Vince Wilfork Foundation to Donate Backpacks and School Supplies to Boston-Area Students
|16 Sep 2013||
Merck Millipore Named One of the Top Charitable Contributors by the Boston Business Journal
Merck Millipore Named One of the Top Charitable Contributors by the Boston Business Journal
|17 Sep 2013||
Merck Millipore Introduces Novel Clarisolve Depth Filters
Novel Clarisolve Depth Filters Deliver Unmatched Speed and Efficiency for Single-Stage Clarification of Pretreated Feed Streams
|10 Sep 2013||
Merck Millipore Donates $30,000 to charity: water in Recognition of World Water Week
Merck Millipore today announced a $30,000 donation to charity: water in recognition of World Water Week.
|12 Jul 2013||
Merck Millipore Opens New R&D Center, Expanding Capabilities in Bioavailability Enhancement and Oral Dosage Formulation
The center will accelerate growth of the company’s portfolio of innovative technologies and products that overcome bioavailability and formulation challenges
|06 Jun 2013||
Merck Millipore Direct Detect® and Muse™ Products Named as Finalists in 2013 American Business Awards
The Muse™ Cell Analyzer provides greater accuracy and precision than manual hemocytometry or image-based automated analysis.
|20 May 2013||
Vince Wilfork Visits Merck Millipore’s Jaffrey, NH Manufacturing Facility and Thanks Employees for Supporting the Vince Wilfork Foundation
Since 2011, Merck Millipore has supported the Vince Wilfork Foundation and its efforts to fund critical research at several leading diabetes institutions.
|12 Jun 2013||
Merck Millipore Launches PluriSTEM™ Human ES/iPS Medium for the Expansion of Human Embryonic and Induced Pluripotent Stem Cells
The proprietary formulation includes Activin-A, TGFβ1, and b-FGF to promote stem cell self-renewal and potent small molecule combinations to inhibit unwanted spontaneous differentiation.
|24 Jun 2013||
Merck Millipore Launches Cellvento™ CHO-200 Chemically Defined Cell Culture Medium for Consistent High Performance in Fed-Batch Mode
Cellvento™ CHO-200 medium and its corresponding feeds do not contain hydrolysates or components of unknown composition, resulting in very good lot-to-lot consistency.
|08 Jul 2013||
Merck Millipore Awards Annual Scholarships
This year’s recipients are Emily Caron, daughter of Merck Millipore employee Roger Caron and Alexander Murphy, stepson of Merck Millipore employee Heather Sue Murphy.
|10 Jul 2013||
150 Cyclists from Merck Millipore and Merck Serono Participated in 150 Mile Ride for MS
As a leading supplier of tools and technologies that support research for many chronic diseases including MS, Merck Millipore is proud to support the National Multiple Scleroses Society.
|15 Mar 2012||
Merck Millipore Launches Mobius® CellReady 50 L Single-use Stirred Tank Bioreactor
This new single-use bioreactor allows biopharmaceutical manufacturers to implement robust, single-use technologies that bring their drugs to market faster, with less risk.
|27 Feb 2012||
Merck Millipore Opens its First Lab Water Production Site in China Ming Che™, a China-exclusive brand, is on the way
The opening of this lab water production facility marks another milestone for Merck Millipore in China, reflecting its long term commitment to the market.
|08 May 2013||
Merck Millipore Leadership Recognized with Diabetes Champion Award by JDRF
Christina Shasserre was recognized for Merck Millipore’s support of JDRF, which includes serving as the chair sponsor of the annual “Walk to Cure Diabetes.”
|10 May 2013||
Merck Millipore Receives Chairman’s Award from Massachusetts Governor at Associated Industries of Massachusetts Luncheon
This award recognizes a Massachusetts firm, institution or public agency of any size that has demonstrated excellence in international trade.
|14 May 2013||
Merck Millipore Introduces Magna ChIP® HiSens Chromatin Immunoprecipitation Kits
These new kits enable target chromatin enrichment from both low and high amounts of input chromatin while delivering low backgrounds, high signal-to-noise ratios, and ultra-sensitive detection.
|21 May 2013||
Merck Millipore and PharmaCell to Develop Optimized Large-Scale Expansion and Harvesting of HepaRG® Cells Grown from Bioreactors
The companies will work together to produce protocols and methods for efficient expansion, harvest and use of HepaRG® cells in support of the BALANCE project.
|25 Jun 2012||
Vincent Donovan to Lead BioPharmaceutical Process Solutions at Merck Millipore
Donovan joined Millipore Corporation in 1988 and has held numerous sales leadership roles including Senior Director, North American Field Operations, and Director of Sales.
|04 Jun 2012||
Merck Millipore Demonstrates Successful Scale-up of Human Stem Cells on Microcarriers in the Mobius® CellReady 3 L Single-use Bioreactor
This new application facilitates large-scale production at up to one-third the cost per dose compared to cells grown in flat culture stacks.
|16 May 2012||
Dana Hubbard, Head of Patents for Merck Millipore, named to Boston’s Top Rated Lawyers
This list, created by LexisNexis Matindale-Hubbell, is a peer-reviewed rating of the leading local lawyers who have reached the highest levels of ethical standards and professional excellence.
|01 May 2013||
Andrew Bulpin to Assume Leadership of Process Solutions at Merck Millipore
He will assume leadership effective May 14, 2012 and be based at the company’s U.S. headquarters in Massachusetts.
|12 Feb 2012||
Merck Millipore Adds Millistak® µPod™ Filter to Line of Disposable Depth Filter Systems
With the Millistak+ µPod filter, users can easily connect multiple devices in parallel or series to rapidly screen combinations of media.
|27 Feb 2012||
Merck Millipore Partners with Charles River Laboratories for Improved Viral Clearance Studies
Merck Millipore and Charles River will collaborate to integrate the TrueSpike™ technology into viral clearance services provided by Charles River.
|01 Mar 2012||
Merck Millipore Introduces CellPrime™ Recombinant Human Lysozyme for Increased Protein Recovery From E. coli Production Systems
The increased efficiency offered by CellPrime recombinant human lysozyme, combined with high activity levels, results in a reduction of overall production costs.
|12 Mar 2012||
Merck Millipore and the Centre for Commercialization of Regenerative Medicine Collaborate to Optimize Conditions for Large-scale Stem Cell Cultivation
This joint project will focus on the development of a proprietary monitoring and control methodology, enabling robust growth of adherent human pluripotent stem cells.
|07 Aug 2012||
Merck Millipore Announces Exclusive Agreement with Julphar Diabetes to Offer Non-animal Origin, Recombinant Human Insulin as Cell Culture Media Supplement
CellPrime™ Insulin stimulates the proliferation of cells and aids in carbohydrate metabolism, helping to ensure the long-term viability of various cell lines.
|20 Jun 2012||
Merck Millipore Launches Provantage® Solutions at BIO 2012
Provantage Solutions provide greater control and increased flexibility for both small and large molecule development and manufacturing processes.
|10 Apr 2012||
Third Annual “Merck Millipore Pharma Forum” to Address Latest Developments in Pharmaceutical Raw Materials Industry
Presentations and discussions will explore the recent launch of the new excipients certification program EXCiPACT™.
|10 Jul 2012||
Merck Millipore Introduces Unique Lab Water E-Solution: Millitrack® Compliance
This unique fully-embedded water purification system software has been developed especially for the pharmaceutical, biotech and contract labs that follow GxP regulations.
|20 Sep 2012||
Merck Millipore Announces the Opening of its State-of-the-Art GMP Bioproduction Facility in Martillac, France
The site will serve users of Merck Millipore’s Provantage™ Biodevelopment and Clinical Supply Solutions option that incorporates the latest technologies for upstream and downstream processes.
|12 Sep 2012||
Merck Millipore Named 53rd on the Boston Business Journal’s List of Top Charitable Contributors
“We are very proud to make the Boston Business Journal’s List of Top Charitable Contributors once again,” says Tara Duplaga, Manager of the Merck Millipore Giving Program.
|30 Aug 2012||
Merck Millipore Donates $10,000 to charity: water in Recognition of World Water Week
World Water Week, held this year from August 26 to September 1, provides a forum for conversation and best practices concerning the ongoing clean water crisis in our global community.
|08 Aug 2012||
Merck Millipore Extends its Innovative NovaSeptum® Sterile Sampling Offerings
This novel design protects product integrity and prevents product loss during sample collection, transport and especially during long term storage where stress release can induce leakage.
|06 Aug 2012||
Merck Millipore Launches Mobius® FlexReady Solution with Smart Flexware® Assemblies for Chromatography
The Mobius FlexReady Solution with Smart Flexware Assemblies for Chromatography is a fully-automated system designed to achieve optimum performance.
|22 Aug 2012||
Merck KGaA Acquires Cell Culture Media Specialist Biochrom AG
The acquisition will strengthen Merck Millipore’s Process Solutions business unit, which provides products, services and solutions that simplify production complexity for manufacturers.
|14 Aug 2012||
Merck Millipore Launches PureGenome™ Kits and Reagents for Fast and Efficient Preparation of Next Generation Sequencing Libraries
PureGenome library preparation is a simple, two-step process followed by amplification using Merck Millipore’s ultra-high fidelity KOD Hot Start DNA Polymerase Mastermix.
|05 Jul 2012||
Merck Millipore Wins Prestigious R&D Magazine 100 Award
The Samplicity® Filtration system provides a higher throughput, ergonomic alternative to syringe-tip filters for the preparation of liquid chromatography samples.
|14 May 2012||
Merck Millipore Muse™ Cell Analyzer Wins Prestigious red dot Design Award
Red dot is one of the world’s largest and most prestigious design competitions from Germany, and is one of the most sought-after quality marks for design recognition globally.
|17 Apr 2012||
Merck Millipore Launches Strat-M™ Synthetic Membrane Model for in vitro Transdermal Diffusion Studies
The synthetic membrane can be successfully used in place of human or animal skin to provide information about permeation characteristics of the compound through human skin.
|16 Apr 2012||
Merck Millipore Receives 2012 REBRAND™ 100 Global Award
The goal of Merck Millipore’s rebrand initiative was to support strategic branding during the merger and to define the brand’s positioning, vision, and mission.
|21 Mar 2012||
Merck Millipore Announces Exclusive Supply and Marketing Agreement With Ventria Bioscience to Expand its CellPrime™ Line of Non-animal Origin Products
This product, which utilizes Ventria’s ExpressTec biomanufacturing technology, will be exclusively marketed and distributed by Merck Millipore to its customers on a global basis.
|19 Sep 2012||
Merck Millipore and the Institute of Bioprocess Engineering and Pharmaceutical Technology to Develop Optimized Process Control and Harvesting of Stem Cells Grown from Bioreactors
This project will focus on the development required to ensure removal of microcarriers and any particulates from stem cell products grown in the Mobius® CellReady disposable bioreactor.
|18 Oct 2012||
Merck Millipore’s Process Solutions Business Unit Announces Updated 2013 Pricing For Pharm Chemical Solutions and Biopharm Process Solutions Products
The price adjustments are being driven by recent and anticipated cost increases, macroeconomic trends and inflation among other considerations.
|09 Oct 2012||
Merck Millipore Offers a Comprehensive and Growing Portfolio of Products and Technologies for Bioavailability Enhancement
This includes products for all types of dosage forms that address solubility, PK/PD modification, which must be taken into account for optimized bioavailability in the final drug.
|12 Oct 2012||
Merck Millipore Provides Grant to The Breast Cancer Research Foundation
The fund will be in the form of two grants of $250,000 each over a two-year period, and is the latest development in Merck Millipore’s two-year alliance with BCRF.
|05 Sep 2012||
Merck Millipore Introduces Cellvento™ CHO-100, a Chemically-defined, Non-animal Origin Media for Superior Cell Growth and Productivity
The new media formulation was designed for the long-term growth of Chinese Hamster Ovary (CHO) cells to express antibodies or protein products.
|18 Sep 2012||
Merck Millipore and VeriStem™ Technologies to Develop Purification Methods for Large-scale Stem Cell Production
Large-scale production of stem cells is necessary to enable their advancement into human clinical trials and to effectively deliver the quantities required.
|17 Sep 2012||
Merck Millipore Obtains Global Licensing Agreement for induced Pluripotent Stem(iPS) Cell Patent Technology with iPS Academia Japan, Inc. (AJ)
Under the agreement, Merck Millipore will continue to offer its STEMCCA™ reprogramming kits, which provide a highly efficient, reproducible method for creating iPS cells.
|07 Jan 2013||
Merck Millipore Launches Mobius® FlexReady Solution with Smart Flexware® Assemblies for Tangential Flow Filtration
Unlike traditional single-use processing systems, this modular system is quick and easy to set up, providing the ability to switch from TFF to Chromatography.
|15 Nov 2012||
Merck Millipore Launches Eshmuno® CPX, a Strong Cation Exchanger Optimized for High Resolution and High Productivity
Built on Merck Millipore’s proven Eshmuno resin technology, the new media offers high aggregate removal efficiency and high dynamic binding capacity, supporting highly productive downstream bioprocessing.
|13 Nov 2012||
Merck Millipore Hosts Two Chromatography User Group Meetings
User Group Meetings attract global biotechnology and biopharmaceutical industry professionals, including those in chromatography R&D, process development, production management and engineering.
|01 Nov 2012||
Merck Millipore and Sistemic Collaborate to Identify Control Markers for Stem Cell Production
The two companies are jointly developing a methodology utilizing Sistemic’s microRNA marker detection capability to enable consistent growth of stem cells.
|30 Apr 2013||
Merck Millipore Launches OsteoMAX-XF™, a Fully Defined, Xeno-free Mesenchymal Stem Cell Osteogenic Differentiation Medium
Mineralization can be detected in less than one week, whereas competing products that contain serum require approximately 21 days to produce similar levels of bone formation.
|23 Apr 2013||
New SIRTainty™ Class III HDAC Assay from Merck Millipore Used in Recent Study Demonstrating Novel Mechanism for Activation of SIRT1
Unlike conventional assays that are dependent upon a single pre-labeled fluorescently tagged substrate, the SIRTainty Class III HDAC Assay employs untagged acetylated peptide substrates.
|28 Feb 2013||
Merck Millipore Muse™ Cell Analyzer Wins Prestigious GOOD DESIGN® Award
The Chicago Athenaeum: Museum of Architecture and Design and Metropolitan Arts Press Ltd. present the Museum's annual GOOD DESIGN® Awards Program.
|02 May 2013||
Patent Litigation Settlement and License between Merck Millipore and W. L. Gore & Associates, Inc.
Merck Millipore announced the settlement of patent infringement disputes between Merck Millipore and W.L. Gore & Associates, Inc. in the U.S. District Court for the District of Massachusetts.
|29 Jan 2013||
Expansion of EZ-Product Family for Faster, More Efficient Bioburden Analysis and Microbial Detection in Beverages
The EZ-product family now includes the EZ-Fluo™ rapid detection system, a non-destructive, fluorescent staining-based system for microbial detection.
|14 May 2013||
Magna ChIP® HiSens Chromatin Immunoprecipitation Kits
These new kits enable target chromatin enrichment from both low and high amounts of input chromatin while delivering low backgrounds, high signal-to-noise ratios.
|31 Mar 2012||
Direct Detect™ Biomolecular Quantitation System
A system for rapid, simplified protein quantitation exploits Merck Millipore’s membrane expertise to enable infrared-based measurement of amide bonds in protein chains.